Actively Recruiting

Age: 6Years - 11Years
All Genders
NCT05115968

Single Cell Sequencing of Tonsillar Tissue in Children With OSA

Led by Chinese University of Hong Kong · Updated on 2025-02-13

15

Participants Needed

1

Research Sites

156 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Obstructive sleep apnoea (OSA) in children is a prevalent sleep disorder, and is characterised by repetitive complete or partial upper airway obstruction during sleep. It is an important disease as it is associated with a large spectrum of end-organ morbidities. Adenotonsillar hypertrophy is the commonest cause of OSA in children, however, the cause of the lymphoid tissue hypertrophy in some individuals but not the others remains unknown. To address the cellular heterogeneity and immune cell involvement in adenotonsillar hypertrophy, here, we propose to employ single-cell sequencing analysis to identify the cell-specific expression patterns associated with the disease, which will enhance our understanding of the pathogenesis of tonsillar hypertrophy in children with OSA and may provide directions for development of novel therapy.

CONDITIONS

Official Title

Single Cell Sequencing of Tonsillar Tissue in Children With OSA

Who Can Participate

Age: 6Years - 11Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Chinese children aged 6 to 11 years
  • Habitual snoring at least 3 nights per week
  • Polysomnography confirmed obstructive sleep apnea with an obstructive apnea hypopnea index of 1 or more per hour
  • Adenotonsillar hypertrophy with clinical indication for adenotonsillectomy
  • Non-OSA children with apnea hypopnea index less than 1 per hour undergoing adenotonsillectomy for other reasons such as recurrent tonsillitis
Not Eligible

You will not qualify if you...

  • Previous upper airway surgery
  • Genetic or syndromal diseases
  • Congenital or acquired neuromuscular diseases
  • Congenital or acquired immunodeficiency
  • Known metabolic syndrome
  • Craniofacial abnormalities

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Prince of Wales Hospital

Hong Kong, Hong Kong

Actively Recruiting

Loading map...

Research Team

K

Kate C Chan, MBChB

CONTACT

E

Elly Cheung

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here